caused by a single-celled protozoan organisms belonging to the genus Eimeria. This infectious disease causes serious economic consequences in the animal production without adequate control measures. Therefore coccidiostats, the drugs intended to kill or inhibit protozoa, are administered to the animals as feed additives.
Coccidiostats are authorised for use in chickens for fattening and in rabbits, and to some Administration of coccidiostats to food-producing animals leads to occurrence of unwanted residues in their tissues and products which pose a potential risk to human health (Elliot et al. 1998 ). To protect the health of consumers, maximum residue limits (MRLs) Maduramycin is a polyether carboxylic ionophoric agent authorized according to the Commission Regulation (EC) No 2430/1999 as a coccidiostat for use in chickens for fattening at a minimum/maximum content of active substance in complete feed of 5 mg.kg -1 . The withdrawal period for maduramycin is at least 5 days prior to slaughter (EC 1999) . In contrast to the established WP for maduramycin and the acceptable daily intake (ADI) of 1 mg.kg -1 , set by the MRLs in foodstuffs of animal origin have to be properly controlled in accordance with the Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products (EC 1996) . The strategy of current residue control is based on two sequential steps, screening and confirmation. A screening method is a method used to detect the presence of a substance or class of substances at the level of interest (at or bellow their MRLs) (EC 2002) .
Microbial inhibition tests (MIT) are widely used for screening of residues of pharmacologically active substances in food-producing animals and their animal products. MIT are based on inhibition of the growth of test organisms sensitive to many antibiotics and sulphonamides. Among these tests, the STAR developed at the EU Community Reference Laboratory in Fougères (France) for the screening of antimicrobial residues in milk and muscle is one of the most widely used tests in residue screening (Gaudin et al. 2004; Kožárová et al. 2009; Pikkemaat et al. 2009; Gaudin et al. 2010 On the basis of the results obtained in our preliminary studies (Kožárová and Máté 2000; Kožárová et al. 2002a; Kožárová 2006; Kožárová et al. 2008) and because the STAR has been officially approved for screening food-producing animals and their products for residues of veterinary drugs in Slovakia (CH 12.19. 2006) , the aim of our study was to detect the presence of maduramycin residues in the tissues of broiler chickens and pheasants after oral administration in medicated feed by the STAR. The distribution and depletion of maduramycin was studied in the tissues of both animal species with respect to the day of the WP.
Materials and methods
Experimental animals and preliminary preparation of samples Thirty two-week-old broiler chickens (Gallus gallus, hybrid Ross) and thirty two-week-old ringnecked pheasants (Phasianus colchicus), obtained from the university farms, were used in our experiment. The animals of both animal species were randomly divided to two groups, experimental (n = 20) and control (n = 10), placed in animal-care approved cages with free access to feed and water and fed commercially produced unmedicated feed HYD-03-NORM-TYP and BŽN PLUS, respectively. The feed supplied to experimental animals was medicated with Cygro l % premix (Alpharma BVBA, Belgium) according to recommendations for use (5 mg.kg -1 of the active ingredient in the complete feed). All experimental animals received in-feed maduramycin for 10 days. On the last day of administration of maduramycin (day 0 of the WP), on days 1 -5 of the WP, and on the first day after elapse of the WP (day 6), two chickens and two pheasants from the experimental groups were slaughtered and the respective samples of muscle (thigh and breast), gizzard, liver, heart, kidneys, spleen, lungs were withdrawn and stored at -20 °C until analysis. The chickens and pheasants from the control groups were slaughtered and processed in the same way. The experiment was approved by the Ethical committee of the university and carried out in the approved experimental facility at the University of Veterinary Medicine in Košice (SK 30006 P). 
STAR Media

Maduramycin standard solutions
Maduramycin (Chemos-group, American Cyanamid Company, USA). The stock solution (500 µg.ml -1 ) of the maduramycin standard was prepared by dissolving 5 mg of maduramycin in 10 ml methanol (Merck, Germany). The working solutions of maduramycin were prepared by serial dilutions with sterile distilled water to the final concentration of 50 µg.l -1 . Working solutions were prepared fresh prior to use.
Preparation of test plates
Antibiotic medium 11 adjusted to pH 8.0 was seeded with ready-to-use commercial spore that the operating conditions were systematically respected.
Determination of the detection limit (LOD) of the STAR for maduramycin
A total of 30 µl of each working solution of maduramycin was transferred to two filter paper discs, 9 mm in diameter (Whatman Grade No 1, Whatman International Ltd., UK), which were placed on the surface of the agar medium in Petri plates. The plates were incubated as follows:
the plates seeded with Bacillus subtilis BGA at 30°C for at least 18 h, the plates seeded with Kocuria rhizophila ATCC 9341 at 37°C for at least 24 h, the plates seeded with Bacillus cereus ATCC 11778 at 30°C for at least 18 h, the plates seeded with Escherichia coli ATCC 11303 at 37°C for at least 18 h and the plates seeded with Bacillus stearothermophilus var. calidolactis ATCC 10149 at 55°C for 12-15 h. The lowest concentration of maduramycin standard which completely inhibited the growth and multiplication of the respective test organism of the STAR and produced an inhibition zone was considered LOD of the respective test organism of the STAR for maduramycin. Each working solution of maduramycin standard was tested in six replicates.
Detection of maduramycin residues in broiler chicken and pheasant samples by the STAR
The samples were examined as follows: a cylindrical core 8 mm in diameter and approximately 2 cm long was removed from each frozen sample using a sterile cork borer. Both ends of the 
Reading the test results
After incubation, the plates were evaluated by measuring the width of clear inhibition zones around the tissue samples and the positive control discs and around the filter paper discs moistened with respective solutions of maduramycin standard with a precision of 0.01 mm using a digital caliper (Mitutoyo, Japan). The width of the inhibition zone was measured as the distance between the edge of the disc or the slice or the dried tissue fluid and the outer limit of the inhibition zone. The samples were considered positive if they gave the inhibition zones equal or superior to 2 mm in width on plates seeded with Bacillus subtilis BGA, Kocuria rhizophila ATCC 9341, Bacillus cereus ATCC 11778 and Escherichia coli ATCC 11303, and equal or superior to 4 mm in width on plates seeded with Bacillus stearothermophilus var. calidolactis ATCC 10149. Meat samples found to be positive by at least one of the five agar diffusion tests were considered to contain residues of antibacterial substances. The positive control paper discs should present the inhibition zones set by the method (streptomycin 4.5 ± 1.5 mm, tylosin 5.5 ± 1.5 mm, chlortetracycline 6.0 ± 1.5 mm, ciprofloxacin 5.5 ± 1.5 mm, sulphamethazine 5piz ± 1.5 mm).
Statistical analysis
The data concerning the sizes of inhibition zones are presented as the mean ± standard deviation (SD) of six measures. Statistical analysis was performed using software Microsoft Office Excel 2007. The levels of significance of differences between the days of the residue screening and between the tissues of both animal species were determined by the analysis of variance and t-test.
The differences for statistical significance were judged at the levels p≤0.5, p≤0.01 and p≤0.001.
Confirmation of maduramycin content in animal feeds by liquid chromatography tandem mass spectrometry (LC-MS/MS)
LC-MS/MS analysis of maduramycin in both medicated feeds was carried out according to the procedure reported in our previous study (Tkáčiková et al. 2010) . However, a different sample 
Results
The results of screening for the presence of maduramycin residues in the tissues of broiler chickens and pheasants after in-feed administration are presented in Table 1 . Due to the 5-day WP, established for maduramycin, the presence of maduramycin residues was investigated on day 0 (the last day of maduramycin administration), days 1 -5 (the days of the WP) and day 6
(the first day after elapse of the WP).
<Insert Table 1 around here> All chicken tissues were highly positive for maduramycin not only throughout the WP, but even on the first day following the WP. The mean diameters of the inhibition zones ranged from 4.09 ± 0.37 to 11.28 ± 1.33 mm. The largest inhibition zones were observed on day 3 of the WP (thigh muscle 7.95 ± 1.05 mm, breast muscle 8.07 ± 0.75 mm, gizzard 6.88 ± 1.52 mm, liver 7.65 ± 0.56 mm, heart 6.84 ± 0.30 mm, spleen 8.64 ± 0.54 mm) with the exception of lungs with maximum on day 0 (7.47 ± 0.27 mm) and kidneys with maximum on day 4 of the WP (11.28 ± 1.33 mm). The largest inhibition zones were detected around the kidneys followed by the heart, spleen, thigh muscle, breast muscle, liver, lungs and, finally, gizzard.
It was interesting that we failed to observe a gradual decline in the size of inhibition zones during the WP, as shown in Figure 1 . The only tissue, in which there was a gradual decline in the zones of inhibition, was the lung. In two cases (thigh and breast muscle), the inhibition zones were larger at the end of the WP than at its beginning (thigh p≤0.05). The most significant differences in the size of inhibition zones with respect to the days of the WP were found in the liver (day 1 p≤0.01, day 2 p≤0.01, day 3 p≤0.05, day 4 p≤0.05, day 5 p≤0.01, day 6 p≤0.05) and less significant differences were detected in the gizzard (day 6 p≤0.01).
<Insert Figure 1 around here> Bacillus stearothermophilus var. calidolactis ATCC 10149 of the STAR detected maduramycin residues in the samples of pheasants throughout the period of investigation.
Positivity was detected in the gizzard, liver, heart, kidneys, spleen and lungs. No positive results were detected on day 5 of the WP, however, on day 6, the heart and spleen were positive again.
The mean diameters of the inhibition zones ranged from 1.19 ± 0.07 to 7.30 ± 0.25 mm. The largest inhibition zones were detected around the spleen followed by the heart, kidneys, gizzard, lungs, liver, thigh muscle and, finally, breast muscle.
Again, we failed to observe the gradual decline in the size of the inhibition zones during the WP, as shown in Figure 2 . The increase in the size of the inhibition zones was observed up to day 1 of the WP in the heart (5.85 ± 0.19 mm), up to day 2 in the thigh muscle (3.06 ± 0.68 mm), breast muscle (2.62 ± 0.99 mm), spleen (7.30 ± 0.25 mm) and gizzard, up to day 3 of the WP in the liver (3.65 ± 0.28 mm) and, at last, up to day 4 of the WP in the lungs (4.70 ± 0.42 mm).
A gradual decline in the size of the inhibition zones during the WP was observed only in kidneys. p≤0.001, day 6 p≤0.001) and heart (day 1 p≤0.001, day 2 p≤0.05, day 3 p≤0.05, day 4 p≤0.01, day 5 p≤0.001) and less significant differences were found in the lungs (day 5 p≤0.05).
<Insert calidolactis ATCC 10149 are presented in Table 2 . The results obtained support the data reported in our previous study (Kožárová et al. 2008 ).
<Insert Table 2 around here> Both feed samples were analyzed by LC-MS/MS to check whether the assumed concentration level of maduramycin was obtained. The detection was performed on a triple quadrupole mass spectrometer in multiple reaction monitoring (MRM) mode after ionisation in and they should be detected in bovine, ovine, caprine, porcine and equine animals, poultry, eggs, rabbit meat and the meat of wild game and farmed game (EC 1996) .
Maduramycin is a polyether ionophoric coccidiostat authorised for prevention of coccidiosis in fattening chickens. It is added to the feed in the form of ammonium salt at a minimum/maximum content of active substance in complete feed of 5 mg kg -1 and should be Data on the monitoring of veterinary medicinal product residues and other substances in food of animal origin in the Member States suggest that the human consumer may be exposed to residues of coccidiostats through the consumption of poultry meat and eggs (Technical report of EFSA, 2010). Several analytical approaches have been used to determine the coccidiostat residues in poultry tissues and eggs (Kennedy et al. 1997; Shen et al. 2001; Kožárová et al. 2002b; Dubois et al. 2004; Rokka and Peltonen, 2006; Dubreil-Chéneau et al. 2009; Olejnik et al. 2009; Shao et al., 2009; Stubbings and Bigwood, 2009; Tkáčiková et al. 2010 ), but only a few screening methods based on microbial inhibition have been used to detect their presence in poultry tissues (Kožárová et al. 2002a; Prieto et al. 2003; Aila et al. 2006; Shitandi et al. 2006; Li 2007; Kožárová et al. 2008; Shitandi et al. 2008 ).
The results obtained in our previous studies showed: 1) the sensitivity of the test organism (Kožárová et al. 2002a; Kožárová et al. 2008) ; 3) by using the HPLC and LC-MS/MS techniques, the residues of both coccidiostats in the positive samples were identified and quantified (Kožárová et al. 2002b , Tkáčiková et al. 2010 . The LC-MS/MS method allowed us to detect residues of maduramycin in all examined tissue samples of broiler chickens (heart, muscle, kidneys, liver, gizzard and skin) on the last day of the WP.
Considering the results obtained in our studies mentioned above and because the STAR is the only plate agar diffusion method officially approved for screening food-producing animals and their products for residues of veterinary drugs in Slovakia, we focused our study on detection of maduramycin residues in the tissues of broiler chickens and pheasants after oral administration in medicated feed by the STAR method. The maduramycin residues were investigated throughout residues in all examined tissues of broiler chickens up to day 6 and all these tissues were found positive throughout the period of investigation. The largest inhibition zones were observed in the kidneys followed by the heart, spleen, thigh muscle, breast muscle, liver, lungs and, finally, gizzard. Our results showed that there is a high potential for the presence of maduramycin residues in broiler chickens.
Less positive results were obtained in pheasants. The gizzard, liver, heart, kidneys, spleen and lungs were considered positive up to day 4 of the WP. No positive results were detected in the thigh muscle and breast muscle. The largest inhibition zones were produced by the spleen followed by the heart, kidneys, gizzard, lungs, liver, thigh muscle and, finally, breast muscle. It was interesting that the spleen and heart appeared positive also on the last day of maduramycin residue investigation. Less positive results obtained in pheasants could be attributed to the differences in chemical composition of meat and lower proportion of fat (Suchý et al. 2002; Tucák et al. 2008 ).
The size of the inhibition zone is directly proportional to the concentration of the antibacterial substance within a concentration range specific for each substance. The results obtained in our studies showed that the LOD of maduramycin for Bacillus stearothermophilus var. calidolactis ATCC 10149 of the STAR is 100 µg.l -1 (mean inhibition zone 3.01 ± 0.71 mm).
In our opinion the concentration of maduramycin residues in the positive tissue samples should be higher than 200 µg.kg -1 (mean inhibition zone 3.69 ± 0.72 mm). Because no MRL has been established for maduramycin in edible chicken tissues our evaluation regarding food safety issues was based on MRL of 400-500 µg.kg -1 , established for maduramycin in some countries (USA, Canada, Japan). Maduramycin, at the residual concentration of 500 µg.kg -1 , formed an inhibition zone of 6.09 ± 0.81 mm in diameter. The diameters of the inhibition zones detected on the first day following the WP showed that maduramycin residues in the tissues of broiler chickens may exceed the non-EU established MRL. The only limit set today for maduramycin in food of animal origin from the animal species other than chickens for fattening and turkeys, originating from the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Our results allowed us to state that the establishment of EU MRL for maduramycin in chicken tissues is essential to reduce the risk to consumer's health from the ingestion of maduramycin residues in poultry products and to ensure that the edible chicken tissues are free from maduramycin residues after the elapse of the WP. To find if such tissues are really free from maduramycin residues, all samples showing positive responses must be subjected to further investigation by a specific confirmatory method enabling the substance to be unequivocally identified and, if necessary, quantified at the level of interest (EC 2002) .
Conclusions
An inhibition test is useful for the detection of an antibacterial substance if LOD of this substance is at the level of interest. The level of interest means the concentration of substance in the sample that is significant for determination of its compliance with relevant legislative provisions (EU, 2002) . Because no MRL has been established for maduramycin it is not possible to conclude whether the STAR can be considered a reliable method for detection of maduramycin residues at the level of interest. Our results showed that the STAR may have a potential for the use as a screening test for maduramycin residues in the tissues of broiler chickens and pheasants. The test organism Bacillus stearothermophilus var. calidolactis ATCC 10149 showed higher sensitivity for maduramycin by detecting positive results in both animal species. The STAR is applicable for a broad-spectrum detection of antibiotic residues and, as seen from our study, Bacillus stearothermophilus var. calidolactis ATCC 10149 seems to be a suitable test organism for the screening of the presence of maduramycin residues in poultry. F o r P e e r R e v i e w O n l y 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
